Clinical trial
A Double-blind, Placebo Controlled, Randomized Crossover Trial to Characterize the Mucolytic Effectiveness of Tacholiquine® in Chronic Bronchitis
NCT02515799 is registered in ClinicalTrials.gov with bene-Arzneimittel GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind, Placebo Controlled, Randomized Crossover Trial to Characterize the Mucolytic Effectiveness of Tacholiquine® in Chronic Bronchitis
- Lead sponsor
- bene-Arzneimittel GmbH
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2014
- Completion date
- July 31, 2015
- Enrollment
- 27 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.